NuVasive (NUVA) Q3 Earnings Miss Estimates, 2021 Guidance Down Posted byZacks Equity Research November 10, 2021 Leave a comment on NuVasive (NUVA) Q3 Earnings Miss Estimates, 2021 Guidance Down NuVasive (NUVA) reported lower-than-expected earnings and revenues with COVID-led headwinds and healthcare staffing shortages dampening the Q3 top-line growth.